CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-31 | Berg Aaron EVP, President US | Option exercise | +44,933 | 655,214 | ||
| 2024-01-31 | Berg Aaron EVP, President US | Shares withheld for taxes | −21,954 | $1.24 | $27K | 633,260 |
| 2024-01-31 | Berg Aaron EVP, President US | Option exercise · Restricted Stock Unit | −34,567 | 34,566 | ||
| 2024-01-31 | Berg Aaron EVP, President US | Option exercise · Restricted Stock Unit | −44,933 | 89,867 | ||
| 2024-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +34,567 | 654,974 | ||
| 2024-01-31 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −18,871 | $1.24 | $23K | 636,103 |
| 2024-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +44,933 | 681,036 | ||
| 2024-01-31 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −22,316 | $1.24 | $28K | 658,720 |
| 2024-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Unit | −34,567 | 34,566 | ||
| 2024-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Unit | −44,933 | 89,867 | ||
| 2024-01-31 | Reilly Thomas Charles EVP and CFO | Option exercise | +44,933 | 93,483 | ||
| 2024-01-31 | Reilly Thomas Charles EVP and CFO | Shares withheld for taxes | −24,552 | $1.24 | $30K | 68,931 |
| 2024-01-31 | Reilly Thomas Charles EVP and CFO | Option exercise · Restricted Stock Unit | −44,933 | 89,867 | ||
| 2024-01-22 | Holt Patrick President and CEO | Purchase | +14,426 | $1.09 | $16K | 314,426 |
| 2024-01-10 | Ketchum Steven B Chief Scientific Officer | Option exercise | +51,500 | 648,677 | ||
| 2024-01-10 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −28,270 | $0.97 | $27K | 620,407 |
| 2024-01-10 | Ketchum Steven B Chief Scientific Officer | Grant or award · Restricted Stock Unit | +51,500 | 0 | ||
| 2024-01-10 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Unit | −51,500 | 0 | ||
| 2024-01-10 | Reilly Thomas Charles EVP and CFO | Option exercise | +51,500 | 76,875 | ||
| 2024-01-10 | Reilly Thomas Charles EVP and CFO | Shares withheld for taxes | −28,325 | $0.97 | $27K | 48,550 |
Page 11 of 67 · 1,339 trades